BRENNAN EDWARD J. enters MEDICUS PHARMA LTD. with 86.50K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 12/31/2024ACC: 0000950142-24-003035
Officer· Chief Scientific Officer
Since Dec 2024
86.50K
Baseline shares
100% direct
86.50K
Direct ownership
1 position
119K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares, no par value ("Common Shares")
DirectShares owned86.50K
Total
86.50K direct86.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares, no par value ("Common Shares") | 86.50K | Direct |
| Total | 86.50K | 86.50K direct |
Derivative Holdings3
Warrants (right to buy)
DirectUnderlying security
Common Shares
Underlying shares
24K
Shares owned
N/A
Exercise price
4.64
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Shares
Underlying shares
75K
Shares owned
N/A
Exercise price
0.81
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Shares
Underlying shares
20K
Shares owned
N/A
Exercise price
2.75
Expiration
—
Exercise window
—
Total
Underlying
119K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants (right to buy) Direct | Common Shares | 4.64 | — | — | 24K | N/A |
| Stock Option (right to buy) Direct | Common Shares | 0.81 | — | — | 75K | N/A |
| Stock Option (right to buy) Direct | Common Shares | 2.75 | — | — | 20K | N/A |
| Total | 119K | 0.00 | ||||